GlycoFineChem
Industrial Research
News & Events
This section of our website is the best initial point of contact for journalists with inquiries about GlycoSyn. Our most recent media releases are on this page.
- Jan 2010
A promising new gout treatment co-discovered by Lower Hutt’s Industrial Research Ltd (IRL) has taken an important step towards the world’s largest pharmaceuticals market.
- Oct 2008A vaccine for cancer is being developed by a new collaboration between Victoria Link, the Malaghan Institute, IRL and Grow Wellington.
- Dec 2006IRL’s Distinguished Scientist, Dr Richard Furneaux, has been awarded the Hector Medal from the Royal Society of New Zealand.
- Aug 2006GlycoSyn has nearly completed the manufacture of the key ingredient for a new drug designed to slow the progression of Parkinson’s Disease.
- Jul 2006The active ingredient for a new drug designed to prevent genital herpes and HIV-AIDS will be manufactured in New Zealand with the signing of a major contract.
- Mar 2005Starpharma Holdings Limited (ASX: SPL, USOTC:SPHRY) of Melbourne, Australia and Industrial Research Limited, New Zealand, today announced that they have entered into a joint venture to accelerate the development of carbohydrate functionalised dendrimers (glycodendrimers) for use in therapeutics, antigen presentation and as biologically active compounds.
